DOI: https://doi.org/10.22141/2224-0586.1.80.2017.94463

Effect of different surgical approaches to aortic valve replacement on surgical stress degree and systemic inflammatory response

A.V. Іvanyuk, M.V. Bondar, O.A. Loskutov, A.V. Rudenko, B.M. Todurov

Abstract


The aim of the study was to estimate the effect of minimally invasive J-shaped sternotomy and median sternotomy on the intensity of surgical stress and systemic inflammatory response in aortic valve replacement. The results of the examination of 44 patients undergone minimally invasive approach and 54 patients undergone media sternotomy demonstrated that J-sternotomy was associated with less intensive systemic inflammatory response that has been proved by lower plasma concentrations of basic inflammatory cytokines (TNF-alpha on average 5.8 pg/ml (increased 1.6 times), IL-6 — on ave­rage 5.3 pg/mL (increased 2.3 times)), and some acute-phase proteins (C-reactive protein — on average 23.5 mg/l (increased 1.8 times) and fibrinogen concentrations — on average 1.3 g/l (increased 1.3 times)). As well it has been determined that minimally invasive approach to aortic valve replacement is followed by less severe stress-induced hormonal homeostasis as comparison to the standard median sternotomy, and it objectively confirms the benefits of minimally invasive approach versus media sternotomy.

Keywords


aortic valve replacement; minimally invasive approaches; postoperative stress intensity; stress-induced disruptions of hormonal homeostasis

References


Hassan M, Miao Y, Maraey A, Lincoln J, Brown S, Windsor J, Ricci M. Minimally invasive aortic valve replacement: cost-benefit analysis of ministernotomy versus minithoracotomy approach. Heart Valve Dis. 2015; 24(5): 531-539.

Ghanta RK, Lapar DJ, Kern JA, Kron IL, Speir AM, Fonner E Jr, Quader M, Ailawadi G. Minimally invasive aortic valve replacement provides equivalent outcomes at reduced cost compared with conventional aortic valve replacement: A real-world multi-institutional analysis. J. Thorac. Cardiovasc. Surg. 2015; 149(4): 1060 - 1065. doi: 10.1016/j.jtcvs.2015.01.014.

Alassar Y, Yildirim Y, Pecha S, Detter C., Deuse T., Reichenspurner H. Minimal access median sternotomy for aortic valve replacement in elderly patients. J Cardiothorac Surg. 2013; 20(8):103. doi: 10.1186/1749-8090-8-103.

Bari G, Csepregi L, Bitay M, Bogáts G. The role of ministernotomy in aortic valve surgery. Orv. Hetil 2016; 157(23):901 - 904. doi: 10.1556/650.2016.30450

Fortunato Júnior JA, Fernandes AG, Sesca JR, Paludo R, Paz ME, Paludo L, Pereira ML, Araujo A. Minimally invasive aortic valve replacement: an alternative to the conventional technique. Rev. Bras. Cir. Cardiovasc. 2012; 27(4):570 - 582.

Saidi T, Douglas TS. Minimally invasive transcatheter aortic valve implantation for the treatment of rheumatic heart disease in developing countries. Expert Rev. Med. Devices 2016; 13(10):979 - 985.

Chan WL, Zhou A, Read RJ. Towards engineering hormone-binding globulins as drug delivery agents. PLoS One2014; 9(11):e113402. doi: 10.1371/journal.pone.0113402.

Klieber MA, Underhill C, Hammond GL, Muller YA. Corticosteroid-binding globulin, a structural basis for steroid transport and proteinase-triggered release. J. Biol. Chem. 2007; 282:29594 - 29603.

Li XH, Yao YM. Advances in the research of effects of cholinergic anti-inflammatory pathway on vital organ function and its mechanism. Zhonghua Shao Shang Za Zhi 2016; 32(7):422 - 425. doi: 10.3760/cma.j.issn.1009-2587.2016.07.008.

Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann. Intern. Med 1996; 125:680 - 687.

Sapan HB, Paturusi I, Jusuf I, Patellongi I, Massi MN, Pusponegoro AD, Arief SK, Labeda I, Islam AA, Rendy L, Hatta M.Pattern of cytokine (IL-6 and IL-10) level as inflammation and anti-inflammation mediator of multipleorgan dysfunction syndrome (MODS) in polytrauma. Int. J. Burns Trauma2016; 6(2):37 - 43.

Burman KD, Wartofsky L. Thyroid function in the intensive care unit setting. Crit. Care Clin.2001; 17(1):43 - 57.

Wernerman J, Desaive T, Finfer S, Foubert L, Furnary A, Holzinger U, Hovorka R, Joseph J, Kosiborod M, Krinsley J, Mesotten D, Nasraway S, Rooyackers O, Schultz MJ, Van Herpe T, Vigersky RA, Preiser JC. Continuous glucose control in the ICU: report of a 2013 round table meeting. Crit. Care 2014; 18(3):226. doi: 10.1186/cc13921.

De Block C, Manuel-y-Keenoy B, Rogiers P, Jorens P, Van Gaal L. Glucose control and use of continuous glucose monitoring in the intensive care unit: a critical review. Current Diabetes Reviews 2008; 4(3):234-244.

Kavanagh BP, McCowen KC. Clinical practice. Glycemic control in the ICU. N. Engl. J. Med. 2010; 363(26):2540-2546. doi: 10.1056/NEJMcp1001115.

Preiser JC, Chase JG, Hovorka R, Joseph JI, Krinsley JS, De Block C, Desaive T, Foubert L, Kalfon P, Pielmeier U, Van Herpe T, Wernerman J. Glucose Control in the ICU: A Continuing Story. J. Diabetes Sci Technol. 2016; 10(6):1372 - 1381.

Nguyen PT, Lewis JG, Sneyd J, Lee RS, Torpy DJ, Shorten PR. Development of a formula for estimating plasma free cortisol concentration from a measured total cortisol concentration when elastase-cleaved and intact corticosteroid binding globulin coexist. J. Steroid Biochem. Mol. Biol.2014; 141:16 - 25. doi: 10.1016/j.jsbmb.2013.12.015.

Lin HY, Muller YA, Hammond GL. Molecular and structural basis of steroid hormone binding and release from corticosteroid-binding globulin. Mol. Cell. Endocrinol. 2010; 316(1):3-12. doi: 10.1016/j.mce.2009.06.015.




Copyright (c) 2017 EMERGENCY MEDICINE

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта